Vivus CEO Expects FDA Approval in April

Leland Wilson, Vivus CEO, discusses the optimist outlook for his company after an FDA panel backed its new diet drug, Qnexa; marketing strategies for the new product; and whether his company is now a potential takeover target, with the Fast Money traders.
00:00
Mon, Feb 27 201212:29 PM EST